Literature DB >> 34852348

Evaluation of Microvascular Patterns Alone Using Endocytoscopy with Narrow-Band Imaging for Diagnosing Gastric Cancer.

Yusuke Horiuchi1, Toshiaki Hirasawa1, Naoki Ishizuka2, Junki Tokura1, Mitsuaki Ishioka1, Yoshitaka Tokai1, Ken Namikawa1, Shoichi Yoshimizu1, Akiyoshi Ishiyama1, Toshiyuki Yoshio1, Junko Fujisaki1.   

Abstract

INTRODUCTION: Although endocytoscopy (EC) with narrow-band imaging (NBI) is effective in diagnosing gastric cancer, no diagnostic system has been validated. We explored a specific diagnostic system for gastric cancer using EC with NBI.
METHODS: Equal numbers of images from cancerous and noncancerous areas (114 images each) were assessed by endoscopists with (development group: 33) and without (validation group: 28) specific training in magnifying endoscopy with NBI. Microvascular and microsurface patterns (MS) in each image were evaluated. Lesions were diagnosed as cancerous when patterns were deemed "irregular." The accuracy, sensitivity, specificity, positive predictive value, and negative predictive value of a diagnosis according to patterns on EC with NBI (microvascular pattern [MV] alone, MS alone, and both) were evaluated and compared between groups to determine the diagnostic performance.
RESULTS: In the development and validation groups, diagnoses based on the MV alone had significantly higher accuracy (91.7% vs. 76.3%, p < 0.0001 and 92.5% vs. 67.5%, p < 0.0001, respectively) and sensitivity (88.6% vs. 68.3%, p < 0.0001 and 89.5% vs. 38.6%, p < 0.0001, respectively) than those based on the MS alone. In both groups, there were no significant differences in diagnostic accuracy between using the MV alone and both patterns. DISCUSSION/
CONCLUSION: Evaluation of the MV alone is a simple and accurate diagnostic method for gastric cancer. This system could find widespread applications in clinical practice.
© 2021 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Diagnostic system; Gastric carcinoma; Magnifying endoscopy; Microsurface pattern

Mesh:

Year:  2021        PMID: 34852348      PMCID: PMC8984999          DOI: 10.1159/000520276

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  25 in total

Review 1.  The diagnosis and management of gastric cancer.

Authors:  Sri G Thrumurthy; M Asif Chaudry; Daniel Hochhauser; Muntzer Mughal
Journal:  BMJ       Date:  2013-11-04

2.  A newly developed continuous zoom-focus endocytoscope.

Authors:  Youichi Kumagai; Kaiyo Takubo; Kenro Kawada; Morihiro Higashi; Toru Ishiguro; Jun Sobajima; Minoru Fukuchi; Kei-Ichiro Ishibashi; Erito Mochiki; Junko Aida; Tatsuyuki Kawano; Hideyuki Ishida
Journal:  Endoscopy       Date:  2016-11-14       Impact factor: 10.093

3.  Diagnostic accuracy of demarcation using magnifying endoscopy with narrow-band imaging for Helicobacter pylori-uninfected undifferentiated-type early gastric cancer.

Authors:  Yusuke Horiuchi; Junko Fujisaki; Noriko Yamamoto; Shoichi Yoshimizu; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Yorimasa Yamamoto; Masatsugu Nagahama; Hiroshi Takahashi; Tomohiro Tsuchida
Journal:  Gastric Cancer       Date:  2018-03-13       Impact factor: 7.370

Review 4.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  William H Allum; Jane M Blazeby; S Michael Griffin; David Cunningham; Janusz A Jankowski; Rachel Wong
Journal:  Gut       Date:  2011-06-24       Impact factor: 23.059

5.  Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer.

Authors:  Yusuke Horiuchi; Junko Fujisaki; Noriko Yamamoto; Tomoki Shimizu; Yuji Miyamoto; Hideomi Tomida; Chika Taniguchi; Kenjiro Morishige; Masami Omae; Akiyoshi Ishiyama; Toshiyuki Yoshio; Toshiaki Hirasawa; Yorimasa Yamamoto; Tomohiro Tsuchida; Masahiro Igarashi; Toshifusa Nakajima; Hiroshi Takahashi
Journal:  Gastric Cancer       Date:  2014-12-10       Impact factor: 7.370

6.  Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype.

Authors:  Ana Ferro; Bárbara Peleteiro; Matteo Malvezzi; Cristina Bosetti; Paola Bertuccio; Fabio Levi; Eva Negri; Carlo La Vecchia; Nuno Lunet
Journal:  Eur J Cancer       Date:  2014-03-17       Impact factor: 9.162

7.  Magnifying endoscopy for diagnosing and delineating early gastric cancer.

Authors:  K Yao; G K Anagnostopoulos; K Ragunath
Journal:  Endoscopy       Date:  2009-05-05       Impact factor: 10.093

8.  A novel ability of endocytoscopy to diagnose histological grade of differentiation in T1 colorectal carcinomas.

Authors:  Tomoya Sako; Shin-Ei Kudo; Hideyuki Miyachi; Kunihiko Wakamura; Kenta Igarashi; Masashi Misawa; Yuichi Mori; Toyoki Kudo; Takemasa Hayashi; Atsushi Katagiri; Fumio Ishida; Takeshi Azuma; Haruhiro Inoue; Shigeharu Hamatani
Journal:  Endoscopy       Date:  2017-09-29       Impact factor: 10.093

9.  In vivo histological diagnosis for gastric cancer using endocytoscopy.

Authors:  Issei Tsurudome; Ryoji Miyahara; Kohei Funasaka; Kazuhiro Furukawa; Masanobu Matsushita; Takeshi Yamamura; Takuya Ishikawa; Eizaburo Ohno; Masanao Nakamura; Hiroki Kawashima; Osamu Watanabe; Masato Nakaguro; Akira Satou; Yoshiki Hirooka; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

10.  Japanese gastric cancer treatment guidelines 2018 (5th edition).

Authors: 
Journal:  Gastric Cancer       Date:  2020-02-14       Impact factor: 7.370

View more
  1 in total

1.  Additive effect of evaluating microsurface and microvascular patterns using magnifying endoscopy with narrow-band imaging in gastric cancer: a post-hoc analysis of a single-center observational study.

Authors:  Yusuke Horiuchi; Toshiaki Hirasawa; Naoki Ishizuka; Junki Tokura; Mitsuaki Ishioka; Yoshitaka Tokai; Ken Namikawa; Shoichi Yoshimizu; Akiyoshi Ishiyama; Toshiyuki Yoshio; Junko Fujisaki
Journal:  BMC Gastroenterol       Date:  2022-03-16       Impact factor: 3.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.